MAPT and Alzheimer disease: The concentrations of the critical markers Aβ1-42, T-tau, P-tau181, neurofilament light chain (NfL), and glial fibrillary acidic protein (GFAP) in the cerebrospinal fluid have diagnostic value in diagnosing AD (Bjerke and Engelborghs, 2018).